Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Irrigation of Parotid Glands in Primary Sjögren's Syndrome
NCT01316770Phase 2Terminated
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- May 2011
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjögren's syndrome comparing Dexamethasone Side with Placebo Side (2 arms). Primary endpoint: Change in Parotid Salivary Flow From Baseline at Day 56. Started May 2011; status: terminated.
02
Drugs
dexamethasone
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT01316770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316770.